Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neonatal Infections Caused by Multidrug-Resistant Bacteria: An Analysis of Prevalence, Risk Factors, and Therapeutic Implications-A Narrative Review.

Pathogens (Basel, Switzerland)·2026
Same author

Salivary Prevalence of Four Oral Pathogens in Postpartum Women in Northeast Romania: An Exploratory Cross-Sectional Study.

Pathogens (Basel, Switzerland)·2026
Same author

Kidney Transplant Recipients: Viral Infections and Malignancies.

Pathogens (Basel, Switzerland)·2026
Same author

Seeding the Future: How Feeding Mode Shapes the Infant Gut Microbiota.

Microorganisms·2026
Same author

Evolution of Antimicrobial Resistance in <i>Acinetobacter baumannii</i> and <i>Pseudomonas aeruginosa</i> in Romania: A Narrative Review of Published Data (2001-2024).

Microorganisms·2026
Same author

Seven Years of <i>Salmonella</i>: Changing Resistance and Clinical Insights.

Microorganisms·2025

Related Experiment Video

Updated: Mar 26, 2026

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

5.1K

THE NEED FOR HBV GENOTYPING: A COST-EFFICIENT APPROACH.

A S Luca, Ramona Gabriela Ursu, Teodora Teuşan

    Revista Medico-Chirurgicala a Societatii De Medici Si Naturalisti Din Iasi
    |January 23, 2016
    PubMed
    Summary

    This study introduces a cost-effective genotyping algorithm for chronic hepatitis B (CHB) patients. It aids physicians in identifying individuals at risk of disease progression and selecting optimal antiviral therapies.

    More Related Videos

    An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
    19:57

    An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

    Published on: March 30, 2014

    19.5K
    Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
    11:14

    Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

    Published on: November 7, 2018

    19.0K

    Related Experiment Videos

    Last Updated: Mar 26, 2026

    Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
    04:11

    Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

    Published on: December 15, 2023

    5.1K
    An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
    19:57

    An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

    Published on: March 30, 2014

    19.5K
    Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
    11:14

    Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

    Published on: November 7, 2018

    19.0K

    Area of Science:

    • Hepatology
    • Virology
    • Medical Diagnostics

    Background:

    • Chronic hepatitis B (CHB) infection outcomes vary, with progression to cirrhosis or inactive carrier states.
    • Ten distinct HBV genotypes and numerous subtypes exist, each with unique geographical distributions.
    • Effective genotyping methods are crucial for managing CHB patients.

    Purpose of the Study:

    • To develop a cost-efficient genotyping diagnosis algorithm for CHB patients.
    • To identify patients at high risk for disease progression.
    • To provide a tool for physicians to determine optimal antiviral therapy.

    Main Methods:

    • Development of a novel, cost-effective genotyping algorithm.
    • Validation of the algorithm's diagnostic efficiency.
    • Comparative analysis with existing genotyping methods.

    Main Results:

    • The proposed algorithm demonstrates high cost-efficiency.
    • Successful identification of CHB patients with varying risk profiles.
    • Facilitation of genotype-specific treatment strategies.

    Conclusions:

    • The developed algorithm is a valuable tool for managing CHB.
    • It aids in predicting disease progression and guiding therapy selection.
    • This approach supports personalized medicine in hepatitis B treatment.